Osiris Therapeutics, Inc. Net Profit Margin 2010-2018 | OSIR
Osiris Therapeutics, Inc. net profit margin from 2010 to 2018. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2018-12-31 | $0.14B | $0.04B | 25.87% |
| 2018-09-30 | $0.14B | $0.01B | 4.44% |
| 2018-06-30 | $0.13B | $0.01B | 7.75% |
| 2018-03-31 | $0.12B | $0.01B | 7.26% |
| 2017-12-31 | $0.12B | $0.01B | 7.56% |
| 2017-09-30 | $0.10B | $-0.03B | -32.29% |
| 2017-06-30 | $0.09B | $-0.04B | -43.96% |
| 2017-03-31 | $0.09B | $-0.04B | -46.51% |
| 2015-12-31 | $0.08B | $-0.04B | -46.25% |
| 2015-09-30 | $0.09B | $0.00B | 2.25% |
| 2015-06-30 | $0.08B | $0.00B | 4.94% |
| 2015-03-31 | $0.07B | $0.00B | 1.43% |
| 2014-12-31 | $0.06B | $-0.00B | -1.69% |
| 2014-09-30 | $0.05B | $0.05B | 100.00% |
| 2014-06-30 | $0.04B | $0.05B | 118.42% |
| 2014-03-31 | $0.03B | $0.04B | 143.33% |
| 2013-12-31 | $0.02B | $0.04B | 170.83% |
| 2013-09-30 | $0.02B | $-0.01B | -63.16% |
| 2013-06-30 | $0.01B | $-0.01B | -92.86% |
| 2013-03-31 | $0.01B | $-0.01B | -118.18% |
| 2012-12-31 | $0.01B | $-0.01B | -137.50% |
| 2012-09-30 | $0.01B | $-0.00B | -50.00% |
| 2012-06-30 | $0.00B | $0.00B | 100.00% |
| 2012-03-31 | $0.00B | $0.01B | 500.00% |
| 2011-12-31 | $0.00B | $0.02B | 1500.00% |
| 2011-09-30 | $0.00B | $0.01B | inf% |
| 2011-06-30 | $0.00B | $0.02B | inf% |
